Sealing of Coronary Perforations With a Second-Generation Covered Stent Graft - Results From the PAST-PERF Registry
- PMID: 33132086
- DOI: 10.1016/j.carrev.2020.10.012
Sealing of Coronary Perforations With a Second-Generation Covered Stent Graft - Results From the PAST-PERF Registry
Abstract
Background: The PAST-PERF registry was initiated to collect data on the PK Papyrus covered stent, a second-generation device for the treatment of coronary artery perforations with enhanced mechanical properties, but with limited available data.
Methods: Patients treated for coronary artery perforations with the PK Papyrus stent at 14 international centers were retrospectively identified. The primary effectiveness outcome was successful sealing of the perforation. The primary safety outcome was a composite of all-cause mortality, definite or probable stent thrombosis, myocardial infarction and target lesion revascularization.
Results: Among the 94 included patients, 72.3% (68/94) had Ellis type III and cavity spilling perforations. Complete sealing was achieved in 93.6% (n = 88), and no sealing could be achieved in 3.2% (n = 3, including one patient with a geographical miss and one patient in whom the device could not be implanted). Pericardiocentesis was required in 25.0% (n = 23), emergency cardiac surgery was needed in 7.6% (n = 7), acute stent thrombosis was observed in 1.1% (n = 1), and in-hospital mortality occurred in 11.7% (n = 11). The median follow-up duration was 283 (IQR:40;670) days. At 6 and 12 months, the incidence of the primary safety endpoint was 26.6% [95%CI:18.6;37.1] and 32.0% [95%CI:22.8;43.4], mortality 15.0% [95%CI:9.0;24.6] and 19.0% [95%CI:11.3;30.0], and target lesion revascularization 5.5% [95%CI:2.0;14.6] and 7.7% [95%CI:3.1;18.2]. Two definite stent thrombosis occurred, one during the procedure and one on post-procedure day 233.
Conclusions: The registry demonstrates favorably high rates of successful stent delivery and sealing of coronary perforations using a second-generation covered stent with low target lesion revascularization and stent thrombosis rates.
Annotated table of content: The PAST-PERF registry demonstrates favorably high rates of successful stent delivery and sealing of coronary perforations using a second-generation covered stent with low target lesion revascularization and stent thrombosis rates. Specifically, complete sealing was achieved in 93.6% of patients (n = 88/94), and no sealing could be achieved in 3.2% (n = 3, including one patient with a geographical miss and one patient in whom the device could not be implanted). The 12-month mortality was 19.0% [95%CI:11.3;30.0], the rate of target lesion revascularization was 7.7% [95%CI:3.1;18.2], and two definite stent thromboses occurred (one during procedure and one on post-procedure day 233).
Keywords: Coronary artery disease; Coronary artery perforation; Covered stent; Percutaneous coronary intervention.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement Ralf Birkemeyer reports grants and non-financial support from Biotronik during the conduct of the study; and personal fees and non-financial support from Biotronik outside the submitted work, Farrel Hellig reports personal fees from Biotronik outside the submitted work, and Eric Eeckhout reports grants from Biotronik outside the submitted work. Dirk Westermann reports non-financial support from Biotronik during the conduct of the study; personal fees from AstraZeneca, personal fees from Bayer, personal fees from Berlin-Chemie, personal fees from Novartis, and non-financial support from Medtronic outside the submitted work.The other authors declare no conflict of interest.
Comment in
-
Hans Brinker and the Silver Skates: A Story of How to Seal A Perforation.Cardiovasc Revasc Med. 2021 Apr;25:27-28. doi: 10.1016/j.carrev.2021.01.006. Epub 2021 Jan 19. Cardiovasc Revasc Med. 2021. PMID: 33478859 No abstract available.
Similar articles
-
PK Papyrus covered stent: Device description and early experience for the treatment of coronary artery perforations.Catheter Cardiovasc Interv. 2019 Oct 1;94(4):564-568. doi: 10.1002/ccd.28306. Epub 2019 Apr 29. Catheter Cardiovasc Interv. 2019. PMID: 31033148
-
Clinical Experience of the PK Papyrus Covered Stent in Patients With Coronary Artery Perforations: Results From a Multi-Center Humanitarian Device Exemption Survey.Cardiovasc Revasc Med. 2022 Oct;43:97-101. doi: 10.1016/j.carrev.2022.04.009. Epub 2022 Apr 25. Cardiovasc Revasc Med. 2022. PMID: 35504818
-
Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry.Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1247-1255. doi: 10.1002/ccd.27789. Epub 2018 Sep 23. Catheter Cardiovasc Interv. 2018. PMID: 30244520
-
Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.Catheter Cardiovasc Interv. 2020 Dec;96(7):1360-1366. doi: 10.1002/ccd.28646. Epub 2019 Dec 18. Catheter Cardiovasc Interv. 2020. PMID: 31850685
-
PK Papyrus coronary stent system: the ultrathin struts polyurethane-covered stent.Future Cardiol. 2020 Sep;16(5):405-411. doi: 10.2217/fca-2020-0022. Epub 2020 May 12. Future Cardiol. 2020. PMID: 32397835 Review.
Cited by
-
A case report of left main perforation treated with BeGraft covered stent.Eur Heart J Case Rep. 2022 Jun 6;6(6):ytac230. doi: 10.1093/ehjcr/ytac230. eCollection 2022 Jun. Eur Heart J Case Rep. 2022. PMID: 35734630 Free PMC article. No abstract available.
-
Applying Principles of Regenerative Medicine to Vascular Stent Development.Front Bioeng Biotechnol. 2022 Mar 7;10:826807. doi: 10.3389/fbioe.2022.826807. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35321023 Free PMC article. Review.
-
Comparative safety and efficacy of new-generation single-layer polytetrafluorethylene- versus polyurethane-covered stents in patients with coronary artery perforation for the RECOVER (REsults after percutaneous interventions with COVERed stents) Investigators.Cardiovasc Interv Ther. 2025 Apr;40(2):296-305. doi: 10.1007/s12928-025-01084-y. Epub 2025 Feb 7. Cardiovasc Interv Ther. 2025. PMID: 39918675 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous